A Single-And Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-890 Tablets in Healthy Chinese Subjects

NCT06506591 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: WD-890
DRUG: WD-890 Tablets Placebo

Sponsor

Zhejiang Wenda Pharma Technology LTD.